MERIDIAN BIOSCIENCE INC.
MERIDIAN BIOSCIENCE INC.
Open: -
Change: -
Volume: -
Low: -
High: -
High / Low range: -
Type: Stocks
Ticker: VIVO
ISIN:

MERIDIAN BIOSCIENCE INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Meridian Bioscience, Inc. - VIVO

  • 152
MERIDIAN BIOSCIENCE INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Meridian Bioscience, Inc. - VIVO

PR Newswire

NEW ORLEANS, Jan. 12, 2018 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Meridian Bioscience, Inc. (NasdaqGS: VIVO).  

Kahn Swick & Foti, LLC ("KSF") - - not all law firms are created equal.  Visit www.ksfcounsel.com to learn more about KSF. (PRNewsfoto/Kahn Swick & Foti, LLC)

On January 25, 2017, the Company revealed negative 1Q2017 financial results, reducing revenue guidance for the fiscal year and a reduction to the annual indicated dividend rate.  Then, on May 17, 2017, a safety notice was issued by the U.S. Food and Drug Administration ("FDA") advising that consumers halt the use of the Company's lead poisoning testing system due to a product recall. Then, on October 23, 2017, the Company was issued a warning letter from the FDA, which was explained by the FDA in its accompanying press release was the result of "several violations of federal law" including "marketing significantly modified versions of two of its blood lead testing systems without the FDA's required clearance or approval and failing to submit medical device reports to the FDA after becoming aware of customer complaints involving discrepancies in blood lead test results."  Thereafter, the Company and certain of its executives were sued in a securities class action lawsuit for failing to disclose material information, violating federal securities laws. 

KSF's investigation focuses on whether Meridian's officers and/or directors breached their fiduciary duties to Meridian's shareholders or otherwise violated state or federal laws. 

If you have information that would assist KSF in its investigation, or have been a long-term holder of Meridian shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn ([email protected]).

About Kahn Swick & Foti, LLC

KSF, whose partners include Former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities, antitrust and consumer class actions, along with merger & acquisition and breach of fiduciary litigation against publicly traded companies on behalf of shareholders. The firm has offices in New York, California and Louisiana.

To learn more about KSF, you may visit www.ksfcounsel.com.

Contact:

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-877-515-1850
206 Covington St.
Madisonville, LA 70447

 

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/meridian-bioscience-investigation-initiated-by-former-louisiana-attorney-general--kahn-swick--foti-llc-investigates-the-officers-and-directors-of-meridian-bioscience-inc--vivo-300582150.html

SOURCE Kahn Swick & Foti, LLC

PR Newswire
PR Newswire

PR Newswire's news distribution, targeting, monitoring and marketing solutions help you connect and engage with target audiences across the globe.